HSV Testing Market Maintains Global Leadership Through Diagnostic Innovation and Accessibility
The global HSV Testing Market is projected to surge from USD 640.5 million in 2025 to USD 1,142.7 million by 2035, registering a robust CAGR of 6%. This 78.4% growth underscores increasing demand for precise diagnostic solutions amid the global rise in herpes simplex virus infections. Heightened awareness of sexually transmitted diseases (STDs), combined with rapid advancements in molecular and point-of-care diagnostics, is propelling market expansion across major regions including Asia Pacific, Europe, North America, and Saudi Arabia. Explore trends before investing – request a sample report today! Rising Diagnostic Demand and Rapid Technological Integration From 2025 to 2030, the HSV testing market is expected to grow by USD 226.4 million—representing nearly half of its decade-long expansion. Increased screening awareness, integration of molecular testing in clinical laboratories, and the rise of home-care diagnostics are key contributors. Diagnostic leaders...